NCT00547092

Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an Erection

A Multicenter Open-Label Study to Determine Treatment Preference of Tadalafil (IC351, LY450190) or Sildenafil Citrate in the Oral Treatment of Erectile Dysfunction

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 386 (actual)
• Sponsor: Eli Lilly and Company · Industry
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To determine if men prefer tadalafil or sildenafil for getting and keeping an erection after treatment with both drugs.

Conditions

• Impotence

Interventions

Type	Name	Description
DRUG	tadalafil	10 mg or 20 mg tadalafil tablets, as needed, no more than once a day, by mouth for 12 weeks (8 week treatment experience phase and a 4 week treatment assessment phase)
DRUG	sildenafil	25 mg, 50 mg, or 100 mg sildenafil citrate tablets, as needed, no more than once a day, by mouth for 12 weeks (8 week treatment experience phase and a 4 week treatment assessment phase)

Timeline

• Start date: 2003-10-01
• Completion: 2004-11-01
• First posted: 2007-10-22
• Last updated: 2007-10-22

Locations

1 site across 1 country: United Kingdom